Cellular Biomedicine Group, Inc.: key financial figures for fiscal year 2019 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2019)
- $339.9K
- Net Income/Loss (FY2019)
- -$50.0M
- Total Assets (FY2019)
- $97.3M
- Total Equity (FY2019)
- $55.7M
- Cash Flows from Operating Activities (FY2019)
- -$39.6M
Source: Cellular Biomedicine Group, Inc. 10-K filing (FY2019). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
